2018
DOI: 10.1007/s10147-018-1351-y
|View full text |Cite
|
Sign up to set email alerts
|

Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
138
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
9
1

Relationship

4
6

Authors

Journals

citations
Cited by 115 publications
(140 citation statements)
references
References 49 publications
1
138
1
Order By: Relevance
“…The current primary treatment for cervical cancer is surgery, radiotherapy and chemotherapy (8). Although improvements have been made, there remain limitations associated with the current treatment options (9). Recurrent cervical cancer and metastasis occur frequently in patients with advanced cervical cancer (10).…”
Section: Introductionmentioning
confidence: 99%
“…The current primary treatment for cervical cancer is surgery, radiotherapy and chemotherapy (8). Although improvements have been made, there remain limitations associated with the current treatment options (9). Recurrent cervical cancer and metastasis occur frequently in patients with advanced cervical cancer (10).…”
Section: Introductionmentioning
confidence: 99%
“…Current guidelines from multiple organizations do not recommend peritoneal cytology evaluation as a standard practice [2,38]. Based on our results and others, it may be useful to integrate peritoneal cytology testing as a routine surgical procedure at the time of radical hysterectomy for early-stage cervical cancer, as it appears that malignant peritoneal cytology can potentially impact survival.…”
Section: Clinical Implicationmentioning
confidence: 87%
“…All patients underwent a review of their medical history and lifestyle habits (smoking-positive: Current smokers of ≥10 cigarettes/day; alcohol intake-positive: Alcohol intake of ≥14 g/day), physical examination and routine clinical staging. The patients were treated according to the Japan Society of Gynecologic Oncology clinical The presence of chronic diseases contributes to the occurrence risk factors for gynecological cancers in Japan guidelines (14)(15)(16). The treatment options for gynecological cancer included surgery, radiotherapy and/or chemotherapy, depending on tumor stage and additional risk factors.…”
Section: Methodsmentioning
confidence: 99%